1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Antispasmodics Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Oral 1.2.3 Injectable 1.2.4 Others 1.3 Market by Application 1.3.1 Global Antispasmodics Drugs Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Special Clinic 1.3.4 Home Care 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Antispasmodics Drugs Market Perspective (2016-2027) 2.2 Antispasmodics Drugs Growth Trends by Regions 2.2.1 Antispasmodics Drugs Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Antispasmodics Drugs Historic Market Share by Regions (2016-2021) 2.2.3 Antispasmodics Drugs Forecasted Market Size by Regions (2022-2027) 2.3 Antispasmodics Drugs Industry Dynamic 2.3.1 Antispasmodics Drugs Market Trends 2.3.2 Antispasmodics Drugs Market Drivers 2.3.3 Antispasmodics Drugs Market Challenges 2.3.4 Antispasmodics Drugs Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Antispasmodics Drugs Players by Revenue 3.1.1 Global Top Antispasmodics Drugs Players by Revenue (2016-2021) 3.1.2 Global Antispasmodics Drugs Revenue Market Share by Players (2016-2021) 3.2 Global Antispasmodics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Antispasmodics Drugs Revenue 3.4 Global Antispasmodics Drugs Market Concentration Ratio 3.4.1 Global Antispasmodics Drugs Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Antispasmodics Drugs Revenue in 2020 3.5 Antispasmodics Drugs Key Players Head office and Area Served 3.6 Key Players Antispasmodics Drugs Product Solution and Service 3.7 Date of Enter into Antispasmodics Drugs Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Antispasmodics Drugs Breakdown Data by Type 4.1 Global Antispasmodics Drugs Historic Market Size by Type (2016-2021) 4.2 Global Antispasmodics Drugs Forecasted Market Size by Type (2022-2027) 5 Antispasmodics Drugs Breakdown Data by Application 5.1 Global Antispasmodics Drugs Historic Market Size by Application (2016-2021) 5.2 Global Antispasmodics Drugs Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Antispasmodics Drugs Market Size (2016-2027) 6.2 North America Antispasmodics Drugs Market Size by Type 6.2.1 North America Antispasmodics Drugs Market Size by Type (2016-2021) 6.2.2 North America Antispasmodics Drugs Market Size by Type (2022-2027) 6.2.3 North America Antispasmodics Drugs Market Size by Type (2016-2027) 6.3 North America Antispasmodics Drugs Market Size by Application 6.3.1 North America Antispasmodics Drugs Market Size by Application (2016-2021) 6.3.2 North America Antispasmodics Drugs Market Size by Application (2022-2027) 6.3.3 North America Antispasmodics Drugs Market Size by Application (2016-2027) 6.4 North America Antispasmodics Drugs Market Size by Country 6.4.1 North America Antispasmodics Drugs Market Size by Country (2016-2021) 6.4.2 North America Antispasmodics Drugs Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Antispasmodics Drugs Market Size (2016-2027) 7.2 Europe Antispasmodics Drugs Market Size by Type 7.2.1 Europe Antispasmodics Drugs Market Size by Type (2016-2021) 7.2.2 Europe Antispasmodics Drugs Market Size by Type (2022-2027) 7.2.3 Europe Antispasmodics Drugs Market Size by Type (2016-2027) 7.3 Europe Antispasmodics Drugs Market Size by Application 7.3.1 Europe Antispasmodics Drugs Market Size by Application (2016-2021) 7.3.2 Europe Antispasmodics Drugs Market Size by Application (2022-2027) 7.3.3 Europe Antispasmodics Drugs Market Size by Application (2016-2027) 7.4 Europe Antispasmodics Drugs Market Size by Country 7.4.1 Europe Antispasmodics Drugs Market Size by Country (2016-2021) 7.4.2 Europe Antispasmodics Drugs Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Antispasmodics Drugs Market Size (2016-2027) 8.2 Asia-Pacific Antispasmodics Drugs Market Size by Type 8.2.1 Asia-Pacific Antispasmodics Drugs Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Antispasmodics Drugs Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Antispasmodics Drugs Market Size by Type (2016-2027) 8.3 Asia-Pacific Antispasmodics Drugs Market Size by Application 8.3.1 Asia-Pacific Antispasmodics Drugs Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Antispasmodics Drugs Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Antispasmodics Drugs Market Size by Application (2016-2027) 8.4 Asia-Pacific Antispasmodics Drugs Market Size by Region 8.4.1 Asia-Pacific Antispasmodics Drugs Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Antispasmodics Drugs Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Antispasmodics Drugs Market Size (2016-2027) 9.2 Latin America Antispasmodics Drugs Market Size by Type 9.2.1 Latin America Antispasmodics Drugs Market Size by Type (2016-2021) 9.2.2 Latin America Antispasmodics Drugs Market Size by Type (2022-2027) 9.2.3 Latin America Antispasmodics Drugs Market Size by Type (2016-2027) 9.3 Latin America Antispasmodics Drugs Market Size by Application 9.3.1 Latin America Antispasmodics Drugs Market Size by Application (2016-2021) 9.3.2 Latin America Antispasmodics Drugs Market Size by Application (2022-2027) 9.3.3 Latin America Antispasmodics Drugs Market Size by Application (2016-2027) 9.4 Latin America Antispasmodics Drugs Market Size by Country 9.4.1 Latin America Antispasmodics Drugs Market Size by Country (2016-2021) 9.4.2 Latin America Antispasmodics Drugs Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Antispasmodics Drugs Market Size (2016-2027) 10.2 Middle East & Africa Antispasmodics Drugs Market Size by Type 10.2.1 Middle East & Africa Antispasmodics Drugs Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Antispasmodics Drugs Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Antispasmodics Drugs Market Size by Type (2016-2027) 10.3 Middle East & Africa Antispasmodics Drugs Market Size by Application 10.3.1 Middle East & Africa Antispasmodics Drugs Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Antispasmodics Drugs Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Antispasmodics Drugs Market Size by Application (2016-2027) 10.4 Middle East & Africa Antispasmodics Drugs Market Size by Country 10.4.1 Middle East & Africa Antispasmodics Drugs Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Antispasmodics Drugs Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Allergan 11.1.1 Allergan Company Details 11.1.2 Allergan Business Overview 11.1.3 Allergan Antispasmodics Drugs Introduction 11.1.4 Allergan Revenue in Antispasmodics Drugs Business (2016-2021) 11.1.5 Allergan Recent Development 11.2 Hikma Pharmaceuticals 11.2.1 Hikma Pharmaceuticals Company Details 11.2.2 Hikma Pharmaceuticals Business Overview 11.2.3 Hikma Pharmaceuticals Antispasmodics Drugs Introduction 11.2.4 Hikma Pharmaceuticals Revenue in Antispasmodics Drugs Business (2016-2021) 11.2.5 Hikma Pharmaceuticals Recent Development 11.3 Lannett 11.3.1 Lannett Company Details 11.3.2 Lannett Business Overview 11.3.3 Lannett Antispasmodics Drugs Introduction 11.3.4 Lannett Revenue in Antispasmodics Drugs Business (2016-2021) 11.3.5 Lannett Recent Development 11.4 Mylan 11.4.1 Mylan Company Details 11.4.2 Mylan Business Overview 11.4.3 Mylan Antispasmodics Drugs Introduction 11.4.4 Mylan Revenue in Antispasmodics Drugs Business (2016-2021) 11.4.5 Mylan Recent Development 11.5 Nexus Pharmaceuticals 11.5.1 Nexus Pharmaceuticals Company Details 11.5.2 Nexus Pharmaceuticals Business Overview 11.5.3 Nexus Pharmaceuticals Antispasmodics Drugs Introduction 11.5.4 Nexus Pharmaceuticals Revenue in Antispasmodics Drugs Business (2016-2021) 11.5.5 Nexus Pharmaceuticals Recent Development 11.6 Akorn 11.6.1 Akorn Company Details 11.6.2 Akorn Business Overview 11.6.3 Akorn Antispasmodics Drugs Introduction 11.6.4 Akorn Revenue in Antispasmodics Drugs Business (2016-2021) 11.6.5 Akorn Recent Development 11.7 Aurobindo Pharma 11.7.1 Aurobindo Pharma Company Details 11.7.2 Aurobindo Pharma Business Overview 11.7.3 Aurobindo Pharma Antispasmodics Drugs Introduction 11.7.4 Aurobindo Pharma Revenue in Antispasmodics Drugs Business (2016-2021) 11.7.5 Aurobindo Pharma Recent Development 11.8 Daiichi Sankyo 11.8.1 Daiichi Sankyo Company Details 11.8.2 Daiichi Sankyo Business Overview 11.8.3 Daiichi Sankyo Antispasmodics Drugs Introduction 11.8.4 Daiichi Sankyo Revenue in Antispasmodics Drugs Business (2016-2021) 11.8.5 Daiichi Sankyo Recent Development 11.9 Fresenius Kabi 11.9.1 Fresenius Kabi Company Details 11.9.2 Fresenius Kabi Business Overview 11.9.3 Fresenius Kabi Antispasmodics Drugs Introduction 11.9.4 Fresenius Kabi Revenue in Antispasmodics Drugs Business (2016-2021) 11.9.5 Fresenius Kabi Recent Development 11.10 Shanghai Fosun Pharmaceutical 11.10.1 Shanghai Fosun Pharmaceutical Company Details 11.10.2 Shanghai Fosun Pharmaceutical Business Overview 11.10.3 Shanghai Fosun Pharmaceutical Antispasmodics Drugs Introduction 11.10.4 Shanghai Fosun Pharmaceutical Revenue in Antispasmodics Drugs Business (2016-2021) 11.10.5 Shanghai Fosun Pharmaceutical Recent Development 11.11 SunGen Pharma 11.11.1 SunGen Pharma Company Details 11.11.2 SunGen Pharma Business Overview 11.11.3 SunGen Pharma Antispasmodics Drugs Introduction 11.11.4 SunGen Pharma Revenue in Antispasmodics Drugs Business (2016-2021) 11.11.5 SunGen Pharma Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Antispasmodics Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Oral Table 3. Key Players of Injectable Table 4. Key Players of Others Table 5. Global Antispasmodics Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Antispasmodics Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Antispasmodics Drugs Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Antispasmodics Drugs Market Share by Regions (2016-2021) Table 9. Global Antispasmodics Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Antispasmodics Drugs Market Share by Regions (2022-2027) Table 11. Antispasmodics Drugs Market Trends Table 12. Antispasmodics Drugs Market Drivers Table 13. Antispasmodics Drugs Market Challenges Table 14. Antispasmodics Drugs Market Restraints Table 15. Global Antispasmodics Drugs Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Antispasmodics Drugs Market Share by Players (2016-2021) Table 17. Global Top Antispasmodics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antispasmodics Drugs as of 2020) Table 18. Ranking of Global Top Antispasmodics Drugs Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Antispasmodics Drugs Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Antispasmodics Drugs Product Solution and Service Table 22. Date of Enter into Antispasmodics Drugs Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million) Table 25. Global Antispasmodics Drugs Revenue Market Share by Type (2016-2021) Table 26. Global Antispasmodics Drugs Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Antispasmodics Drugs Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Antispasmodics Drugs Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Antispasmodics Drugs Revenue Market Share by Application (2016-2021) Table 30. Global Antispasmodics Drugs Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Antispasmodics Drugs Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million) Table 33. North America Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million) Table 35. North America Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Antispasmodics Drugs Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Antispasmodics Drugs Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Antispasmodics Drugs Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Antispasmodics Drugs Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Antispasmodics Drugs Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Antispasmodics Drugs Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Antispasmodics Drugs Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Antispasmodics Drugs Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Antispasmodics Drugs Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Antispasmodics Drugs Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Antispasmodics Drugs Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Antispasmodics Drugs Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Antispasmodics Drugs Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Antispasmodics Drugs Market Size by Country (2022-2027) & (US$ Million) Table 62. Allergan Company Details Table 63. Allergan Business Overview Table 64. Allergan Antispasmodics Drugs Product Table 65. Allergan Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 66. Allergan Recent Development Table 67. Hikma Pharmaceuticals Company Details Table 68. Hikma Pharmaceuticals Business Overview Table 69. Hikma Pharmaceuticals Antispasmodics Drugs Product Table 70. Hikma Pharmaceuticals Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 71. Hikma Pharmaceuticals Recent Development Table 72. Lannett Company Details Table 73. Lannett Business Overview Table 74. Lannett Antispasmodics Drugs Product Table 75. Lannett Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 76. Lannett Recent Development Table 77. Mylan Company Details Table 78. Mylan Business Overview Table 79. Mylan Antispasmodics Drugs Product Table 80. Mylan Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 81. Mylan Recent Development Table 82. Nexus Pharmaceuticals Company Details Table 83. Nexus Pharmaceuticals Business Overview Table 84. Nexus Pharmaceuticals Antispasmodics Drugs Product Table 85. Nexus Pharmaceuticals Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 86. Nexus Pharmaceuticals Recent Development Table 87. Akorn Company Details Table 88. Akorn Business Overview Table 89. Akorn Antispasmodics Drugs Product Table 90. Akorn Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 91. Akorn Recent Development Table 92. Aurobindo Pharma Company Details Table 93. Aurobindo Pharma Business Overview Table 94. Aurobindo Pharma Antispasmodics Drugs Product Table 95. Aurobindo Pharma Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 96. Aurobindo Pharma Recent Development Table 97. Daiichi Sankyo Company Details Table 98. Daiichi Sankyo Business Overview Table 99. Daiichi Sankyo Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 100. Daiichi Sankyo Recent Development Table 101. Fresenius Kabi Company Details Table 102. Fresenius Kabi Business Overview Table 103. Fresenius Kabi Antispasmodics Drugs Product Table 104. Fresenius Kabi Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 105. Fresenius Kabi Recent Development Table 106. Shanghai Fosun Pharmaceutical Company Details Table 107. Shanghai Fosun Pharmaceutical Business Overview Table 108. Shanghai Fosun Pharmaceutical Antispasmodics Drugs Product Table 109. Shanghai Fosun Pharmaceutical Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 110. Shanghai Fosun Pharmaceutical Recent Development Table 111. SunGen Pharma Company Details Table 112. SunGen Pharma Business Overview Table 113. SunGen Pharma Antispasmodics Drugs Product Table 114. SunGen Pharma Revenue in Antispasmodics Drugs Business (2016-2021) & (US$ Million) Table 115. SunGen Pharma Recent Development Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global Antispasmodics Drugs Market Share by Type: 2020 VS 2027 Figure 2. Oral Features Figure 3. Injectable Features Figure 4. Others Features Figure 5. Global Antispasmodics Drugs Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Special Clinic Case Studies Figure 8. Home Care Case Studies Figure 9. Others Case Studies Figure 10. Antispasmodics Drugs Report Years Considered Figure 11. Global Antispasmodics Drugs Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 12. Global Antispasmodics Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Antispasmodics Drugs Market Share by Regions: 2020 VS 2027 Figure 14. Global Antispasmodics Drugs Market Share by Regions (2022-2027) Figure 15. Global Antispasmodics Drugs Market Share by Players in 2020 Figure 16. Global Top Antispasmodics Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antispasmodics Drugs as of 2020 Figure 17. The Top 10 and 5 Players Market Share by Antispasmodics Drugs Revenue in 2020 Figure 18. Global Antispasmodics Drugs Revenue Market Share by Type (2016-2021) Figure 19. Global Antispasmodics Drugs Revenue Market Share by Type (2022-2027) Figure 20. North America Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 21. North America Antispasmodics Drugs Market Share by Type (2016-2027) Figure 22. North America Antispasmodics Drugs Market Share by Application (2016-2027) Figure 23. North America Antispasmodics Drugs Market Share by Country (2016-2027) Figure 24. United States Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Canada Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 27. Europe Antispasmodics Drugs Market Share by Type (2016-2027) Figure 28. Europe Antispasmodics Drugs Market Share by Application (2016-2027) Figure 29. Europe Antispasmodics Drugs Market Share by Country (2016-2027) Figure 30. Germany Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. France Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. U.K. Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Italy Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Russia Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Nordic Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 37. Asia-Pacific Antispasmodics Drugs Market Share by Type (2016-2027) Figure 38. Asia-Pacific Antispasmodics Drugs Market Share by Application (2016-2027) Figure 39. Asia-Pacific Antispasmodics Drugs Market Share by Region (2016-2027) Figure 40. China Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. Japan Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. South Korea Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. Southeast Asia Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. India Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Australia Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 47. Latin America Antispasmodics Drugs Market Share by Type (2016-2027) Figure 48. Latin America Antispasmodics Drugs Market Share by Application (2016-2027) Figure 49. Latin America Antispasmodics Drugs Market Share by Country (2016-2027) Figure 50. Mexico Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Brazil Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 53. Middle East & Africa Antispasmodics Drugs Market Share by Type (2016-2027) Figure 54. Middle East & Africa Antispasmodics Drugs Market Share by Application (2016-2027) Figure 55. Middle East & Africa Antispasmodics Drugs Market Share by Country (2016-2027) Figure 56. Turkey Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. Saudi Arabia Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. UAE Antispasmodics Drugs Market Size YoY Growth (2016-2027) & (US$ Million) Figure 59. Allergan Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 60. Hikma Pharmaceuticals Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 61. Lannett Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 62. Mylan Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 63. Nexus Pharmaceuticals Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 64. Akorn Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 65. Aurobindo Pharma Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 66. Daiichi Sankyo Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 67. Fresenius Kabi Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 68. Shanghai Fosun Pharmaceutical Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 69. SunGen Pharma Revenue Growth Rate in Antispasmodics Drugs Business (2016-2021) Figure 70. Bottom-up and Top-down Approaches for This Report Figure 71. Data Triangulation Figure 72. Key Executives Interviewed

Allergan Hikma Pharmaceuticals Lannett Mylan Nexus Pharmaceuticals Akorn Aurobindo Pharma Daiichi Sankyo Fresenius Kabi Shanghai Fosun Pharmaceutical SunGen Pharma